FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384341129> ?p ?o ?g. }

• W4384341129 endingPage "1001" @default.
• W4384341129 startingPage "1001" @default.
• W4384341129 abstract "Glaucoma is a progressive optic neuropathy characterized by a rise in the intraocular pressure (IOP) leading to optic nerve damage. Bimatoprost is a prostaglandin analogue used to reduce the elevated IOP in patients with glaucoma. The currently available dosage forms for Bimatoprost suffer from relatively low ocular bioavailability. The objective of this study was to fabricate and optimize solid lipid nanoparticles (SLNs) containing Bimatoprost for ocular administration for the management of glaucoma. Bimatoprost-loaded SLNs were fabricated by solvent evaporation/ultrasonication technique. Glyceryl Monostearate (GMS) was adopted as solid lipid and poloxamer 407 as surfactant. Optimization of SLNs was conducted by central composite design. The optimized formulation was assessed for average particle size, entrapment efficiency (%), zeta potential, surface morphology, drug release study, sterility test, isotonicity test, Hen’s egg test-chorioallantoic membrane (HET-CAM) test and histopathology studies. The optimized Bimatoprost-loaded SLNs formulation had an average size of 183.3 ± 13.3 nm, zeta potential of −9.96 ± 1.2 mV, and encapsulation efficiency percentage of 71.8 ± 1.1%. Transmission electron microscopy (TEM) study revealed the nearly smooth surface of formulated particles with a nano-scale size range. In addition, SLNs significantly sustained Bimatoprost release for up to 12 h, compared to free drug (p < 005). Most importantly, HET-CAM test nullified the irritancy of the formulation was verified its tolerability upon ocular use, as manifested by a significant reduction in mean irritation score, compared to positive control (1% sodium dodecyl sulfate; p < 0.001). Histopathology study inferred the absence of any signs of cornea tissue damage upon treatment with Bimatoprost optimized formulation. Collectively, it was concluded that SLNs might represent a viable vehicle for enhancing the corneal permeation and ocular bioavailability of Bimatoprost for the management of glaucoma." @default.
• W4384341129 created "2023-07-15" @default.
• W4384341129 creator A5000550245 @default.
• W4384341129 creator A5006052467 @default.
• W4384341129 creator A5016820951 @default.
• W4384341129 creator A5027759136 @default.
• W4384341129 creator A5047080452 @default.
• W4384341129 creator A5049046810 @default.
• W4384341129 creator A5051642655 @default.
• W4384341129 creator A5057566854 @default.
• W4384341129 date "2023-07-13" @default.
• W4384341129 modified "2023-09-30" @default.
• W4384341129 title "Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma" @default.
• W4384341129 cites W1497063116 @default.
• W4384341129 cites W1972311825 @default.
• W4384341129 cites W1972354143 @default.
• W4384341129 cites W1980884204 @default.
• W4384341129 cites W1988413525 @default.
• W4384341129 cites W2015452026 @default.
• W4384341129 cites W2018516156 @default.
• W4384341129 cites W2021214738 @default.
• W4384341129 cites W2028839775 @default.
• W4384341129 cites W2033309869 @default.
• W4384341129 cites W2034742711 @default.
• W4384341129 cites W2040957717 @default.
• W4384341129 cites W2040958523 @default.
• W4384341129 cites W2048274021 @default.
• W4384341129 cites W2050323177 @default.
• W4384341129 cites W2059291872 @default.
• W4384341129 cites W2060111182 @default.
• W4384341129 cites W2077082297 @default.
• W4384341129 cites W2085566410 @default.
• W4384341129 cites W2097737743 @default.
• W4384341129 cites W2105624158 @default.
• W4384341129 cites W2115305419 @default.
• W4384341129 cites W2147081834 @default.
• W4384341129 cites W2437504278 @default.
• W4384341129 cites W2539812081 @default.
• W4384341129 cites W2590279635 @default.
• W4384341129 cites W2734869630 @default.
• W4384341129 cites W2756746367 @default.
• W4384341129 cites W2803725601 @default.
• W4384341129 cites W2810682312 @default.
• W4384341129 cites W2890882648 @default.
• W4384341129 cites W2896879109 @default.
• W4384341129 cites W2927115307 @default.
• W4384341129 cites W2983007045 @default.
• W4384341129 cites W3006984756 @default.
• W4384341129 cites W3093318653 @default.
• W4384341129 cites W3120678266 @default.
• W4384341129 cites W3156774485 @default.
• W4384341129 cites W3183164963 @default.
• W4384341129 cites W4200259478 @default.
• W4384341129 cites W4212913959 @default.
• W4384341129 cites W4225854525 @default.
• W4384341129 cites W4303969168 @default.
• W4384341129 cites W4380991056 @default.
• W4384341129 cites W73589935 @default.
• W4384341129 cites W2118494938 @default.
• W4384341129 doi "https://doi.org/10.3390/ph16071001" @default.
• W4384341129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37513913" @default.
• W4384341129 hasPublicationYear "2023" @default.
• W4384341129 type Work @default.
• W4384341129 citedByCount "0" @default.
• W4384341129 crossrefType "journal-article" @default.
• W4384341129 hasAuthorship W4384341129A5000550245 @default.
• W4384341129 hasAuthorship W4384341129A5006052467 @default.
• W4384341129 hasAuthorship W4384341129A5016820951 @default.
• W4384341129 hasAuthorship W4384341129A5027759136 @default.
• W4384341129 hasAuthorship W4384341129A5047080452 @default.
• W4384341129 hasAuthorship W4384341129A5049046810 @default.
• W4384341129 hasAuthorship W4384341129A5051642655 @default.
• W4384341129 hasAuthorship W4384341129A5057566854 @default.
• W4384341129 hasBestOaLocation W43843411291 @default.
• W4384341129 hasConcept C118487528 @default.
• W4384341129 hasConcept C136229726 @default.
• W4384341129 hasConcept C155672457 @default.
• W4384341129 hasConcept C171250308 @default.
• W4384341129 hasConcept C192562407 @default.
• W4384341129 hasConcept C199529486 @default.
• W4384341129 hasConcept C2776521421 @default.
• W4384341129 hasConcept C2777336333 @default.
• W4384341129 hasConcept C2778527774 @default.
• W4384341129 hasConcept C2779820397 @default.
• W4384341129 hasConcept C71924100 @default.
• W4384341129 hasConcept C86181022 @default.
• W4384341129 hasConceptScore W4384341129C118487528 @default.
• W4384341129 hasConceptScore W4384341129C136229726 @default.
• W4384341129 hasConceptScore W4384341129C155672457 @default.
• W4384341129 hasConceptScore W4384341129C171250308 @default.
• W4384341129 hasConceptScore W4384341129C192562407 @default.
• W4384341129 hasConceptScore W4384341129C199529486 @default.
• W4384341129 hasConceptScore W4384341129C2776521421 @default.
• W4384341129 hasConceptScore W4384341129C2777336333 @default.
• W4384341129 hasConceptScore W4384341129C2778527774 @default.
• W4384341129 hasConceptScore W4384341129C2779820397 @default.
• W4384341129 hasConceptScore W4384341129C71924100 @default.
• W4384341129 hasConceptScore W4384341129C86181022 @default.

• next